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Abstract
Coordinated gene transcript levels across tissues (denoted ‘‘gene synchrony’’) reflect converging influences of genetic,
biochemical and environmental factors; hence they are informative of the biological state of an individual. So could brain
gene synchrony also integrate the multiple factors engaged in neuropsychiatric disorders and reveal underlying
pathologies? Using bootstrapped Pearson correlation for transcript levels for the same genes across distinct brain areas, we
report robust gene transcript synchrony between the amygdala and cingulate cortex in the human postmortem brain of
normal control subjects (n=14; Control/Permutated data, p,0.000001). Coordinated expression was confirmed across
distinct prefrontal cortex areas in a separate cohort (n=19 subjects) and affected different gene sets, potentially reflecting
regional network- and function-dependent transcriptional programs. Genewise regional transcript coordination was
independent of age-related changes and array technical parameters. Robust shifts in amygdala-cingulate gene synchrony
were observed in subjects with major depressive disorder (MDD, denoted here ‘‘depression’’) (n=14; MDD/Permutated
data, p,0.000001), significantly affecting between 100 and 250 individual genes (10–30% false discovery rate). Biological
networks and signal transduction pathways corresponding to the identified gene set suggested putative dysregulated
functions for several hormone-type factors previously implicated in depression (insulin, interleukin-1, thyroid hormone,
estradiol and glucocorticoids; p,0.01 for association with depression-related networks). In summary, we showed that
coordinated gene expression across brain areas may represent a novel molecular probe for brain structure/function that is
sensitive to disease condition, suggesting the presence of a distinct and integrated hormone-mediated corticolimbic
homeostatic, although maladaptive and pathological, state in major depression.
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Introduction
Major depression affects more individuals than all other
psychiatric illnesses combined, and a significant number of
patients do not remit after pharmacological or behavioral
treatment [1], hence inflicting a continuous toll on affected
individuals and on society [2]. Changes in the coordinated
function of a neural network comprising cortical and subcortical
brain areas are thought to underlie the mood regulation deficit in
depression [3]. The functional connectivity between two critical
components of this corticolimbic circuitry, the amygdala and
anterior cingulate cortex, potentially mediates the relay of
emotion-related information for cortical processing, and feedback
regulation on amygdala activity [4]. In control non-depressed
subjects, the volume, function and connectivity of these two areas
are affected by serotonin-related gene variants [4,5], together
suggesting that this pathway may be recruited in diseases of altered
mood. Indeed, recent findings suggest an increased task-related
recruitment of rostral cingulate and decreased coactivation of
amygdala and cingulate in depressed patients [6]. Moreover,
studies in depression suggests functional, cellular and molecular
pathologies in both areas [7–10]. So, alterations in the intrinsic
circuitry of the amygdala and anterior cingulate cortex may result
in altered connectivity, deficient cingulate feedback regulation on
amygdala function and abnormal processing of emotion-related
stimuli in depression [11,12].
How can brain region activities be investigated at the molecular
and gene levels? We hypothesized that pathological mechanisms
leading to depression may affect the coordination of gene
expression patterns in the brain, and tested this hypothesis within
a set of related brain areas, the amygdala and the subgenual
anterior cingulate cortex. Our assay makes use of the fact that
correlations in gene transcript levels across samples and datasets
(‘‘coexpression’’ or ‘‘coregulation’’) represent intrinsic attributes of
cellular and biological systems [13,14], including in the human
brain [15,16]. As expected for inter-related biological systems,
many genes show variability in expression that do not reflect
measurement error and that are consistently identified in a range
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are (i) driven by various molecular mechanisms, genetic make-up
and function-dependent synchronization, (ii) central to cellular
function, (iii) link genes of common biological functions [13,17],
and thus can be used to create gene interactions networks [18].
Hence, based on indications that correlated expression profiles
might serve as markers of cellular or tissue relationships, we
investigated synchronized expression across two regions implicated
in the altered mood component of major depression. Confirming
our hypotheses, we show that gene-wise coordinated transcript
levels is a robust component of expression across regions within
subjects, and that major depression is associated with significant
gene-specific alterations in amygdala-cingulate gene coordination.
Results
Large-scale gene transcript synchrony across brain areas
Transcripts for a particular gene are synchronized between two
regions if they display significantly higher correlation across brain
regions compared to permutated data. Here, using gene array data
in the human postmortem brain of control subjects [10] (n=14),
we demonstrate that a large number of genes displayed positive
correlations of transcript levels between amygdala and cingulate
(Figure 1A–D), resulting in a unimodal distribution (Median
r=0.32) (Figure 1E). In contrast, the distribution of the
permutated data, in which the subject linkage across regions was
scrambled centered on the null correlation (Dashed line in
Figure 1E; r=0.014; Control/Permutated, p,0.000001). As no
similar dataset are currently available (See Discussion), we
investigated the presence of regional gene synchrony across a
different set of brain areas. Large-scale gene synchrony was
confirmed between two pre-frontal cortical regions in an
independent cohort [19] (n=19 subjects), and affected different
genes (Figure 1F–G).
Gene coordination is not a result of age-related changes
in gene transcript levels
Age-related genes could produce correlations between gene
expression levels across samples because numerous genes have
strong correlations with age [19] and our subjects are acquired
from a range of ages. It is therefore possible that the permutation
destroys the global shift towards higher correlation (Figure 1E)
simply because it scrambles the age-induced correlations. To
investigate this putative effect, we subtracted age as a contributing
factor and recomputed regional gene transcript correlations (see
Methods and Figure 2B–D for details on age-detrending). As
figure 2A shows, the entire shift towards positive correlation values
across regions via gene coordination was achieved without any
age-correlations in the expression profiles, demonstrating that the
gene expression correlations with age have only an exceedingly
small influence on regional gene coordination.
A genetic confound for these effects was also extremely unlikely
as allelic frequencies for very large gene numbers would need to be
similar within cohort, while being significantly different across
cohorts, in order to generate the observed differences. Moreover,
transcripts with reported impact of genetic variant on array
hybridization and signal level [20] displayed low synchrony in
both sets of brain regions (i.e. COMT; r#0.2, p.0.05), thus ruling
out technical confounders. Finally, regional gene coordination was
observed across a heterogeneous cohort and could not distinguish
the contribution of individual demographic or clinical factors (e.g.
male/female difference, drug exposure; File S1).
Figure 1. Correlated genewise transcript levels across brain regions. A–D Examples of within-subject positive, negative and absent
amygdala-cingulate gene synchrony. E The right-shifted histogram of genewise transcript correlation suggests that the majority of genes are similarly
regulated in both areas. The permutated data (dashed line) is centered on zero, indicating that gene coordination is subject-specific. F A similar
pattern of gene synchrony was observed between two areas of the prefrontal cortex in an independent cohort (‘‘BA’’, Brodman area). G The lack of
correlations in the extent of gene synchrony between the amygdala-cingulate and prefrontal cortical areas demonstrate that different sets of genes
present coordinated transcript levels in the two different sets of brain areas (G, R=0.002). AMY, amygdala, ACC, anterior cingulate cortex.
doi:10.1371/journal.pone.0009970.g001
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gene expression protocols
RMA-based methods (as used here) have superior low-level
detection capability compared to GCOS-MAS5 [21]; however, to
ensure that normalization method was not responsible for the
observed correlations, we recomputed the cross-area correlations
using MAS5-normalized data. We observed similar and highly
significant shifts (p,.000001) to positive levels of coordination for
both amygdala-cingulate and prefrontal cortex regions using
MAS5-normalized data, as we did with GCRMA-normalized data
(not shown). Moreover, normalization-based differences in the
estimated level of coordination were consistent low for highly
coordinated genes, which are the focus of this study.
Technical reliability of array data by quantitative real-
time PCR (qPCR)
qPCR confirmation typically relies on measuring group
differences 20% or greater in magnitude and averaged over
multiple samples. Accordingly, the technical reliability of the
array data used here was previously validated by independent
qPCR measurements (array/qPCR correlation r$0.75; n=,20
genes) [10]. While independent verification of differential
Figure 2. Age-related genes do not significantly influence gene coordination. A Age-detrended bootstrapped estimates of gene
coordination were significantly different from the null permutated model (p,.00001; distribution outlined by black dashed line) and did not decrease
the overall levels of gene coordination, when compared to the original bootstrap estimates (red distribution). B–C Relationships between amygdala-
cingulate coordination and age correlation, before (B) and after (C) removal of any age-correlation indicated that age-detrending did not affect
amygdala-cingulate regional coordination. As shown in C, the distribution of age correlations is centered on zero and highly compressed compared
to figure B. The residual spread in the y-axis is due to inevitable, small, randomly occurring correlations while resampling the detrended data. D
Histogram of correlations between original and detrended amygdala-cingulate coordination levels, showing that the vast majority of genes retain
highly similar regional correlation, thus demonstrating an overall very small contribution of age to regional gene synchrony.
doi:10.1371/journal.pone.0009970.g002
Gene Synchrony in Depression
PLoS ONE | www.plosone.org 3 April 2010 | Volume 5 | Issue 4 | e9970expression changes between groups is a preliminary condition to
establish confidence level in the quality of the gene array dataset
before pursuing gene coregulation studies, measures of coordi-
nated gene expression rely on changes of small magnitude across
individual samples (Main text; Figure 1A–C) that are typically
within the margin of technical variability in qPCR. For instance,
we performed qPCR on 18 additional genes with coordinated
regional expression (ATP5G1, CRHBP, MAOB, NFE2L2,
PHKB, POLR2E, PRKAG2, RXRA, SAT1, AACS, CAP1,
C D C 4 2 ,C R Y Z ,G R L F 1 ,I R F 2 B P 2 ,N E F L ,P A P O L Aa n d
SCN2A2). Samples were run in quadruplicates based on three
internal controls (ACT, GAPDH and CYC). Transcript changes
associated with variable coregulation levels resulted into lower
coefficients of variation by array quantification (CVarray=0.19in
amygdala and cingulate) compared to qPCR values
(CVqPCR=0.37; p,0.005 in amygdala; p,0.0001 in cingulate,
two-group t-tests). This higher CVqPCR potentially reflects the
exponential amplification of PCR reactions compared to the
linear hybridization detection by arrays, and effectively limits the
potential of confirming coregulation by qPCR in this and related
studies. These results are consistent with other studies on
microarray-based gene network, where qPCR is typically used
to validate the mean absolute expression level [22,23]. Instead,
the validity and biological relevance of coordinated gene
expression typically relies on extensive alternative forms of
conformation through combining datasets and through permu-
tation testing procedures (both performed here) [13,17], while
the larger accuracy of gene networks has been confirmed
through functional convergence across groups of affected genes
[13–16].
Altered amygdala-cingulate corticolimbic regional gene
synchrony in depression
We next tested the hypothesis that pathological mechanisms
leading to depression may affect the coordination of gene
expression patterns between the amygdala and cingulate cortex.
Array data from subjects with major depression [10] (n=14; File
S1) displayed a similar amygdala-cingulate gene transcript right-
shifted correlation distribution (Figure 3A; median r=0.32;
MDD/Permutated data, p,0.000001). Transcript synchrony
was similar in control and depressed subjects (Gray dots in
Figure 3B; p,0.000001); hence independently confirming amyg-
dala-cingulate regional gene synchrony in human subjects. Relying
on permutation testing procedures to ensure statistical significance
of coregulation measures and after controlling the false discovery
rate (FDR) (10–30%), as many as 94 gene transcripts displayed
robust significant loss of regional synchrony in depression (Blue in
Figure 3b–c; from greater to 0.7 to less than 0.2 values), while over
180 displayed significant gain of synchrony in depression (Red in
Figure 3B–C; from less than 20.7 to greater than 20.2 values)
(File S2).
Genes with altered transcript synchrony participate in
biological networks and signal transduction pathways
modulated by hormonal factors previously implicated in
depression
To gain insight into biological functions affected by these
changes, we overlaid the top 80 genes (,20% FDR) under both
conditions (gain or loss of synchrony) onto the global molecular
network of the Ingenuity knowledge database. The top gene
networks in both categories displayed similarities, as they included
numerous signal transduction and transcription components of the
mitogen-activated protein kinase pathway (Table 1) and other
genes previously implicated in depression (CREB1 [24], SAT1
[25]). The unbiased inclusion of additional nodes significantly
linked to depression-affected genes identified insulin–a recurrently-
suggested contributor to neuropsychiatric disorders - as a putative
modulator for both networks (Figure 3D; Table 1). The pro-
inflammatory cytokine, interleukin 1 (IL1) was identified as a
second putative modulator (p,0.0001) for the top network formed
by genes with elevated synchrony in depression (Figure 3D;
Table 1). Additional biological modulators identified in the top
three networks in each category included thyroid hormone, a
clinically-useful antidepressant-augmenting agent [26], and beta-
estradiol, the major brain estrogen. All associations of the
identified modulators with the top gene networks were significant
(p,0.05), as assessed by bootstrap resampling. These associations
were also selective (p,0.01), as assessed by repeated testing of the
Ingenuity database with random gene lists of equivalent or
variable sizes of selected genes (60 to 200 genes). Pathways,
biological functions and diseases associated with altered gene
synchrony are summarized in Table 1. Notably, glucocorticoid
receptor signaling was the top canonical pathway associated with
three of the top networks, linking stress hormone-related events - a
well-characterized causative factor [27] - to the deregulated
molecular state in depression.
Discussion
Our findings demonstrate that regional gene synchrony, as
measured by gene-wise correlated transcript levels across brain
regions within individuals, is a major component of gene
expression patterns in the human brain (Figure 1). These patterns
were not explained by genetic, age or microarray effects, and
appeared driven by correlation within subjects, as scrambling the
data across subjects abolished them (Figure 1E–F, Figure 2). Thus
we speculate that regional gene synchrony may partly reflect an
integrated molecular output of function-, and dysfunction-
dependent, regulation of brain areas.
While data from the amygdala/cingulate cortex and from the
two prefrontal cortex areas supports the contention that gene
coordination may reflect an overall, or network-specific, concerted
brain region function, our results are independent of these larger
hypotheses, as we only considered here the functional significance
of those genes which show significant depression-related alteration
in gene synchrony between two regions known to be functionally
affected by depression. Accordingly, by bootstrapping correlations
and controlling the FDR, we identified a robust and conservative
collection of genes that displayed significant gains or losses of
amygdala-cingulate gene transcript coordination in subjects with
depression (Figure 3) (which is distinct from mean absolute
expression level changes; See Comments section). These gene sets
implicated shifts in intracellular signaling, metabolism and cell
growth/structure, and suggested the implication of several
biological modulators previously associated with depression
(Table 1).
Notably, changes in amygdala-cingulate gene synchrony suggest
a combined dysregulated function for several hormone-type
modulators (Figure 3D; Table 1), which together summarize
several key hypotheses for pathophysiological mechanisms in
depression. As postmortem studies preclude investigating short-
term events, we propose that the present findings may correspond
to a stable, chronic and adaptive de novo, although pathological,
state. The integrative nature of this deregulated state departs from
reductionist approaches and has critical implications for our
understanding and modeling of pathological mechanisms of
depression.
Gene Synchrony in Depression
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As coregulated gene expression reflect the influences of genetic,
biochemical and environmental factors [13,28], we speculate that
the observed gene synchrony across regions may reflect a
molecular balance of local brain systems that is achieved over
time (days-months) through the coordinated function and
continuous feedback of interacting brain regions. For instance,
starting at the cellular level, the rate of neuronal firing is
determined by the molecular composition of local neuronal
circuits. The cumulative electric signals of single neurons with
neuronal ensembles oscillate on various timeframes, supporting
regional brain function and underlying correlated functions across
regions. In turn, the translation and integration of neuronal
activity by intracellular signaling cascades is influenced by
coordinated activities across functionally-related brain regions.
Additionally, broad and long-acting modulators (hormones-type
factors) modulate transcriptional programs (through nuclear
receptors, for instance) and interact/modify this conversion of
neuronal activity into cellular changes over time and across areas.
According to this model, the disturbances in biological rhythms
observed in depression (circadian, hormonal cycles) and the known
role of environmental exposure (stress, disease) in precipitating
disease episodes, will influence the degree of cellular exposure to
hormone-type modulators, and may potentially result in an
altered, yet stable, molecular balance. This suggested mechanism
resembles a ‘‘decanalization’’ process that has been proposed for
complex disorders, where chronic shifts in various regulating
factors converge to induce and maintain a departure from the
biologically-optimized healthy organism into a distinct, stable and
maladaptive pathological state [29].
A combined hormone-mediated disease pathology in
major depression
Consistent with the above-proposed model, the unbiased
analysis of biological modulators associated with networks formed
by genes with altered amygdala-cingulate coregulation, identified
Figure 3. Altered amygdala-cingulate regional gene synchrony in subject with major depression. A Global right-shifted histogram of
gene synchrony in subjects affected with depression. B Comparing gene synchrony between control and depressed subjects confirmed that genes
are similarly regulated in both groups (Gray dots) and identified numerous genes with robust decrease (Blue dots: High R in controls, low R in
depression) or increase (Red dots: low R in controls, high R in depression) in amygdala-cingulate synchrony. C Single gene examples. D The top genes
and molecule interaction networks built on genes selected with increased (right) or decreased (left) amygdala-cingulate synchrony in depression
share similarities in signal transduction components and were linked through insulin, a homeostatic modulator with significant links to both networks
(Table 1). IL1 was significantly connected to the network build in genes with increased regional synchrony in depression. Grey, depression-affected
genes; White, genes or bioactive molecules significantly connected to the network.
doi:10.1371/journal.pone.0009970.g003
Gene Synchrony in Depression
PLoS ONE | www.plosone.org 5 April 2010 | Volume 5 | Issue 4 | e9970factors previously implicated in depression or in its treatment
(insulin, beta-estradiol, thyroid hormone, IL1 and glucocorti-
coids; Table 1), although notably, none of them would be
sufficient to reasonably explain the presence of the illness in
heterogeneous clinical cohorts [1,24]. (1) Insulin shared potential
control over genes forming the most robust networks under
conditions of gain and loss of synchrony (Figure 3), suggesting
that deregulation of this homeostatic modulator may participate
in mediating pathological changes in depression. Insulin has been
suggested as a potential mediator of metabolic changes in
neuropsychiatric disorders [30], whereas insulin-resistance is
more frequent in subjects with familial depression [31]. (2)
Thyroid hormone influences brain physiology through regulating
basal metabolism and neuronal maturation. Low thyroid function
is associated with increased incidence of depression, while thyroid
adjuvant therapy augments antidepressant therapy, potentially
through deactivation of limbic regions [26]. (3) Although
associated with mood changes in female subjects, the relevance
of altered estradiol function to this male group is underscored by
local aromatase–mediated conversion of testosterone to estradiol,
including in the amygdala, where it modulates anxiety and
depressive-like behaviors [32]. (4) IL1 is a potent pro-inflamma-
tory cytokine, which mediates aspects of the ‘‘sickness behavior’’,
a syndrome sharing similarities with major depression [33].
Interestingly, IL1 was associated here with increased regional
gene synchrony in depression, suggesting a gain-of-function
mechanism consistent with IL1 recruitment and role. (5) Finally,
as potential core inducing-factors of the illness [27], glucocorti-
coids (and stress) are known to modulate the functions of all other
identified factors, resulting among others in altered blood brain
barrier function, decreased glucose uptake, immune activation,
and disrupted sex hormone cycling or release [26,33,34].
Circulating interleukin and other cytokines also affect insulin
function [33], together suggesting that a complex interplay of
disrupted hormone-mediated regulations of organs and cell
ensembles may occur in depression.
Table 1. Top 3 biological networks formed by genes with gain of loss of amygdala-cingulate gene synchrony.
Net-
work Genes & Molecules in Network Score
Focus
Genes Canonical pathways Major function Disease
HIGH AMY-ACC gene transcript synchrony in MDD (GAIN OF FUNCTION)
1 Akt, ALCAM, Ap1, Calmodulin, CCNB1, CD59,
CDC42, CREM, ERK, ETV5, Histone h3, Hsp90, ICK,
IL1, INSIG1, INSULIN, Jnk, KLF6, MAGI1,
Mapk, MAPK8, Nfat, NFkB (complex), P38 MAPK,
PDGF BB, PPARD, PSMB4, RAD23A, Ras, SAT1,
SCD, SCN2A, SQSTM1, TAC1, UXS1
40 20 Glucocorticoid receptor
signaling; B-cell receptor signaling;
PPAR signaling; Xenobiotic
metabolism; interleukin signaling
Protein kinase cascade;
intracellular signaling
Genetic
disorder
2 AACS, ABCB10, AMACR,C 1 4 O R F 1 0 6 ,C A B C 1 ,C B L L 1 ,
CCDC106,C D K L 3 ,C R E B L 2 ,CRYZ, FAM62A, FBXO9,
HNF4A, IER5, LRRC8C, MRPL18, MRPS15, MRPS27,
NDFIP1, PLA2G12B, RGNEF, RNASE4, RPS18, SCG2,
SH3BGRL2, SREBF1, STK11, TMEM87B, TP53, TPRKB,
TRIM4,T U B E 1 ,WDR77, YWHAZ, ZNF175
27 14 Mitochondrion,
intracellular organelle,
cellular metabolism,
ribosome
Neurolo-
gical
disorder
3 ALDH1B1, ATF7IP2, BETA-ESTRADIOL, CNN2,
CORO1C, CTNNA2, CTNNB1, DSC3, F2, GLRB,
GPR137B, GRB2, IFNB1, IFRD2, IKBKE, LAGE3,
LOC284230, LRRFIP2, MAOB, MYC, PDHB, PFDN5,
PKP4, PUM1, RPL35, RPL21, SLC11A1, SLC16A5, SP1,
SPTLC1, TAGLN3, TGOLN2, UBAP2L, VCL, ZXDB
24 13 cell-cell junction, cell
adhesion, actin-binding
-
LOW AMY-ACC gene transcript synchrony in MDD (LOSS OF NORMAL CONTROL FUNCTION)
1 ABCD3,A c t i n ,Calcineurin protein(s), Ck2, CREB1,
DBN1, ERK, ERK1/2, FSH, FTL, HLA-E, INSULIN,
ITCH,L D L ,MAP2K5, Mapk, MAX, MIRN124,
NCAM1, NFE2L2, NFkB (complex), P38 MAPK,
PCGF2,P D G FB B ,PHLPP, Pkc(s), Proteasome, RFC1,
SAT1, SERPINE1, SLC11A2, SLC30A7, TGFBR2,
TIPARP, tyrosine kinase
41 19 Glucocorticoid receptor
signaling; Xenobiotic metabolism,
NRF2-mediated oxidative stress
response; B-Cell receptor signaling;
PPAR signaling
Protein kinase; intra-
cellular signaling;
Phosphoprotein
-
2 ABHD5, Akt, BETA-ESTRADIOL, CTNNA1, CTNNB1,
DDX21, GPNMB, HNRPDL, HR, IL4, IL13GC,
JAKMIP2, MAP3K1, MIRNLET7G, MYC, PDK1, PNN,
RELA, SAR1B, SLC26A2, SMAD3, SMCR7L, SOCS4,
SPRR2B, SPRR2G, STAG2, TFCP2, TGFB1, THYROID
HORMONE, TNS1, TUBB6, YWHAG, ZFP161,
ZMYM2, ZNF337
40 19 Glucocorticoid receptor
signaling
Regulation of cellular
process: transcription,
metabolism, cell growth
-
3 ADSS, APEH, ARMC6, C11ORF58, CRIPT, DLG4, EML1,
GGCX, GRID2, GTPBP3, GYS2, HLA-B, HNF4A, HSPC152,
LILRB3, LRRC1, LRRC40, MPP1, NLGN4X, OGDH,
PAPOLA, PPP1R10, PPP1R11, PPP1R3D, PPP2R5B,
PTPRG, RIOK2, SEC11A, SEPT2, SGCE, SLC25A1,
SRP68, STYXL1, TPP2, WDR42A
25 13 Protein phosphatase
activity; Cytoskeleton
-
In double-underline are biological modulators significantly connected to the network over a range of FDR’s and unlikely to be selected at random (p,0.01). Depression-
affected genes are in bold. Other included genes/molecules displayed significant interactions with Depression-affected genes in network. ‘‘Canonical pathways’’ contain
genes linked to $25% of nodes in networks. AMY, amygdala; ACC, anterior cingulate cortex; MDD, major depressive disorder.
doi:10.1371/journal.pone.0009970.t001
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consistent for all identified factors, it is conceivable to envision a
model where sustained environmental and lifestyle changes induce
chronic adaptive changes in several systems (insulin, sex-hormones
and thyroid-related functions), which now interacts with individual
genetic make-up or additional environmental disturbances (stress
or infection). Thus this model connects and potentially synergizes
distinct and previously-proposed pathophysiological mechanisms
for depression. Accordingly, pathways to a depressive state are not
likely to be explained by any single factor, but may reflect the
disruption of several hormone-type factors acting on different
timeframes (cyclic, constant, phasic or induced). Here our results
suggest that in depression these factors may converge on
intracellular pathways (e.g., MAPK pathway), mitochondria and
energy metabolism, and on other neurochemical pathways, such
as SAT1 and polyamines [25], resulting in altered function and
cell structure (growth, adhesion) within the amygdala-cingulate
network (Table 1). In conclusion, we propose that the identified
departures in corticolimbic regional gene synchrony represent an
integrated gene/molecular signature of a de novo maladaptive and
pathological state in subjects with major depression.
Limitations and comments
- The present findings demonstrate that regional gene
coordination represents a biological feature of the human brain
across related areas, and that alterations in this phenomenon are
useful for measuring integrated multi-scale effects in complex
disorders such as depression. Our results provide the basis for
further mapping of gene coordination structure onto specific
functional brain networks. Indeed, the extent to which gene
coordination follow the boundaries of known anatomical/
functional networks is still to be determined. For instance, the
amygdala is an anatomical and functional hub [35] and we may
expect positive large-scale gene synchrony with other, but not all
areas.
- Similarly, the question of a control brain region in depression
is often discussed but not clarified. Indeed, it is not know whether
the primary pathology of the illness is region-specific or
widespread and data has been provided for both cases [10,36].
So in short, there is no consensus for a ‘‘control’’ brain region in
depression. An additional practical limitation is that no similar
datasets are currently available to define the limits of the effect of
MDD on regional gene coordination. Finally, critical to our
findings, our results do not depend on other regions being affected
or not, but instead provide information on gene coordination in
areas of a network that is affected in depression. Whether other
brain regions are affected is an important scientific question, but
for which the answer is complementary rather than necessary for
the current study.
- With regards to validating gene coexpression, it is becoming
increasingly clear that there are different types of independent
validation of array data for: 1) differential expression level, 2)
coregulation and 3) functional implications, which in turn require
different analytical approaches. Coregulation relies on changes of
small magnitude across samples that are difficult to replicate by
qPCR. Our results provide a technical reason for the usual
absence of such confirmatory approaches in coregulation studies,
which is that the variability of qPCR measurement is higher than
the one observed in array data. Such information had to our
knowledge not yet been provided in the rapidly growing field of
coregulation studies. Instead, coregulation methods rely on
assessing the probability of confirming the observed effects in
other array datasets and on the probability of results belonging to
common biological pathways. Here, we provide very robust
statistical findings for these two types of validation, using bootstrap
and other resampling statistical approaches. An implication of
these observations is that it may not be wise to rely on single key
genes as modulators of the observed effects, as the statistical
reliability of any individual genes is moderate, compared to the
robust statistical significance of coregulated or functionally-related
gene groups. Here we relied on a process of convergent
confirmation of mediators of depression, across groups of genes
through the well-validated Ingenuity’s literature-based database.
- The mostly positive coordinated patterns may be surprising,
based on known biological interactions between areas and cell
types. Studies in regions with well-characterized neurotransmitter
structures, such as raphe/cortex or ventral tegmental area/nucleus
accumbens may help resolve this question. Notably, the proposed
assay (regional gene synchrony) does not identify a single area of
origin of disease-related changes (an intrinsic limitation of the
approach), but rather suggests changes in factors supporting
synchronization of gene function across brain areas in depression.
- Other factors are likely engaged in the illness, for which the
size and composition of the cohorts did not allow us to identify.
For instance, early developmental events and indirect modulation
(e.g. through monoamine regulation) may be more challenging to
identify and are not necessarily well characterized in currently
available functional gene networks. Finally, although we ruled out
the contribution of several factors (genetic variants, tissue-specific
programs, age) we only speculate that function-dependent
regulation may be at play in supporting the depression-related
correlation shifts. Hence, it will be of critical interest to assess
whether correlated patterns return to control states in remitted
subjects and if such patterns are measurable in rodent models of
the illness. Finally, it is notable that robust coordinated patterns
were observed in a relatively small and heterogeneous cohort of
subjects. Indeed, it is likely that demographic and clinical
parameters, such as sex, race, lifetime stress exposure and
antidepressant exposure for instance, will influence regional gene
synchrony, although much larger cohorts and multi-region gene
arrays datasets will be necessary to investigate the full extent of
these effects. Despite all of these potentially confounding
influences, gene coordination remains a strong influence on
patterns of gene expression across areas, and for which alterations
in depressed subjects correspond to known and suspected
abnormalities in the illness.
Materials and Methods
Cohort description and array parameters
Human cohort 1 (amygdala and cingulate) includes samples
from 28 white male subjects: 14 control subjects and 14 subjects
with familial major depression. Subject description, array sampling
and parameters were previously described [10]. In brief, brain
samples were obtained at the Allegheny County Medical
Examiner’s Office (Pittsburgh) after written consent from next-
of-kin. Consensus DSM-IV diagnoses were made by an indepen-
dent committee of experienced clinical research scientists, utilizing
information from clinical records, toxicology exam and a
standardized psychological autopsy. Depressed and normal
comparison subjects were matched for age, sex and race (File
S1). Amygdala samples were dissected from frozen coronal blocks
,2–3 cm caudal to the temporal pole and were enriched in
lateral, basolateral and basomedian nuclei. Cingulate samples
were harvested from coronal sections in subgenual cingulate and
contained all six cortical layers. All procedures were approved by
the University of Pittsburgh’s Institutional Review Board and by
the Committee for Oversight of Research Involving the Dead. The
Gene Synchrony in Depression
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Subjects description, array parameters and data are available in
[37]. Details about arrays processing and parameters are
summarized in the supplemental files.
Statistical methods
Gene-wise bootstrapped Pearson correlation r-values were used
to ensure an accurate estimation of the ‘‘real’’ underlying
distribution and to avoid spurious findings due to outlying data.
Because gene coordination relies on multiple samples to form a
single measure, we used the percentile bootstrap method to ensure
that the shifts were robust and significant (p,0.05) and then
applied the Benjamini-Hochberg FDR [38]. To increase the
power of the analysis, we considered alterations of coordination in
genes with high correlations in at least one condition, which are
indicative of inter-regional communication [18].
While methods exist to optimize cutoff values in coexpression
networks [28], there are no analogous mathematical methods for
coordinated expression for the same genes. Therefore we used a
0.7 r-value cutoff (resulting in=3244 probesets with cross-area
links) that was indicated as an optimal balance of false positives
and false negatives for within-area amygdala and cingulate
networks [28], and results did not significantly vary for alternative
cutoffs (+/20.1) (not shown). To generate p-values that quantify
the depression-related shift in gene coordination, we used the
percentile bootstrap method. These p-values for shifts in
correlation were estimated using 20,000 bootstrap resamples of
the raw data, at which point p-values were stable.
Methods for eliminating age correlation in microarray
data
While baseline comparison of age (Figure 2B) did not show any
influence of age-correlated genes on the amygdala-cingulate
expression correlations (r=20.01), to avoid ambiguity in the
source of gene coordination we detrended any linear relationship
with age in both amygdala and cingulate data (eliminating the
possible influence of any large magnitude y-values shown in
figure 2B on gene coordination). Because the final correlations
used to assess gene coordination were bootstrapped, to detrend the
data we removed any linear relationship with age in each of the
20,000 bootstrap instances and used these detrended resamples to
generate a histogram of amygdala-cingulate expression profiles as
before (see Figure 2A).
Biological pathway, gene network and modulator
analyses
Selected genes were overlaid on the global molecular network
developed from information contained in the Ingenuity Pathway
knowledge base (www.ingenuity.com). This network is composed
of ,2 million literature-based biological links between genes and
bioactive molecules, and sub-networks are built on genes of
interest based on their connectivity within this global network.
Gene networks were limited to 35 nodes. The score for a network
takes into account the relative numbers of network eligible
molecules, of molecules analyzed and the total number of
molecules in Ingenuity’s knowledge base. These scores are based
on the hypergeometric distribution and represent the negative log
of the right-tailed Fisher’s Exact Test p-value. Disease links are
based on literature-based association with illness. The major
functions of gene clusters were determined by DAVID functional
clustering (http://david.abcc.ncifcrf.gov).
To assess whether the association of the identified biological
modulators with the top networks was specific (p,0.01), we
resampled the Ingenuity database 100 times of with random gene
lists of equivalent sizes. The process was repeated with variable
sizes of selected genes (60 to 200 genes). Finally, the probability of
finding the identified modulators in the top gene networks was
assessed bootstrap resampling.
Supporting Information
File S1 Cohort descriptions and array parameters; AMY-ACC
probeset correlations.
Found at: doi:10.1371/journal.pone.0009970.s001 (0.12 MB
PDF)
File S2 Complete per-probeset amygdala-anterior cingulate
cortex coordination levels and p-values.
Found at: doi:10.1371/journal.pone.0009970.s002 (0.75 MB
XLS)
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